Recombinant Gamma Interferon Stimulates Signal Transduction and Gene Expression in Alveolar Macrophages In Vitro and in Tuberculosis Patients

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Infection and Immunity

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.71.4.2058-2064.2003PMID 12654826PMCID PMC152019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease.

  2015cited by this paper
• Suppressors of cytokine signalling (SOCS) in the immune system

  2002cited by this paper
• Host Defense Responses to Infection by Mycobacterium tuberculosis

  2002cited by this paper
• ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma.

  2001cited by this paper
• ERK1 and ERK2 Activate CCAAAT/Enhancer-binding Protein-β-dependent Gene Transcription in Response to Interferon-γ*

  2001cited by this paper
• Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation

  2001cited by this paper
• Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response1

  2001cited by this paper
• SOCS Proteins: Negative Regulators of Cytokine Signaling

  2001cited by this paper
• Differentiation of Monocytes to Macrophages Switches the Mycobacterium tuberculosis Effect on HIV-1 Replication from Stimulation to Inhibition: Modulation of Interferon Response and CCAAT/Enhancer Binding Protein β Expression1

  2000cited by this paper
• Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium tuberculosis in the Murine Lung

  2000cited by this paper
• Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression.

  2000cited by this paper
• The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferons.

  2000cited by this paper
• The Janus Kinase Inhibitor, JAB/SOCS-1, Is an Interferon-γ Inducible Gene and Determines the Sensitivity to Interferons

  2000cited by this paper
• CCAAT/Enhancer-binding Protein-β Regulates Interferon-induced Transcription through a Novel Element*

  2000cited by this paper
• Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

  1999cited by this paper
• Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1.

  1999cited by this paper
• Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1

  1999cited by this paper
• Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1.

  1999cited by this paper
• Modeling the impact of global tuberculosis control strategies.

  1998cited by this paper
• Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.

  1998cited by this paper
• Local immune responses correlate with presentation and outcome in tuberculosis.

  1998cited by this paper
• Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis.

  1998cited by this paper
• Type I Interferon Induces Inhibitory 16-kD CCAAT/ Enhancer Binding Protein (C/EBP)β, Repressing the HIV-1 Long Terminal Repeat in Macrophages: Pulmonary Tuberculosis Alters C/EBP Expression, Enhancing HIV-1 Replication

  1998cited by this paper
• Identification of nitric oxide synthase as a protective locus against tuberculosis.

  1997cited by this paper
• Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung.

  1997cited by this paper
• Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol.

  1997cited by this paper
• STATs and gene regulation.

  1997cited by this paper
• Interferon gamma-induced transcription of the murine ISGF3gamma (p48) gene is mediated by novel factors.

  1997cited by this paper
• Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro.

  1997cited by this paper
• Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol

  1997cited by this paper
• Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung.

  1996cited by this paper
• A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.

  1996cited by this paper
• Essential and non‐redundant roles of p48 (ISGF3γ) and IRF‐1 in both type I and type II interferon responses, as revealed by gene targeting studies

  1996cited by this paper
• Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.

  1996cited by this paper
• Human host response to Mycobacterium tuberculosis.

  1995cited by this paper
• Accelerated course of human immunodeficiency virus infection after tuberculosis.

  1995cited by this paper
• Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro.

  1995cited by this paper
• Involvement of the IRF-1 transcription factor in antiviral responses to interferons.

  1994cited by this paper
• Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

  1994cited by this paper
• Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF‐1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene.

  1994cited by this paper
• An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

  1993cited by this paper
• Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide

  1993cited by this paper
• Tuberculosis in the 1990s

  1993cited by this paper
• Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection

  1992cited by this paper
• Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha.

  1992cited by this paper
• Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins

  1992cited by this paper
• Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung.

  1991cited by this paper
• Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily.

  1990cited by this paper
• Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either

  1990cited by this paper
• A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

  1989cited by this paper
• Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro.

  1989cited by this paper
• Differential binding of interferon-induced factors to an oligonucleotide that mediates transcriptional activation.

  1989cited by this paper
• Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis.

  1989cited by this paper
• Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice

  year unknowncited by this paper

• Comprehensive review and reflective evaluation of cell therapies for tuberculosis

  2025cites this paper
• Dry powder Inhalation of lytic mycobacteriophages for adjunct therapy in a mouse model of infection with Mycobacteriumtuberculosis.

  2025cites this paper
• Geraniin inhibits whole blood IFN-γ and IL-6 and promotes IL-1β and IL-8, and stimulates calcium-dependent and sucrose-sensitive erythrocyte death.

  2022cites this paper
• Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries

  2022cites this paper
• The Relationship of Serum Levels of Gamma Interferon and its Receptor (CD119) to Development of BCG Axillary Lymphadenopathy

  2019cites this paper
• ESAT-6 modulates Calcimycin-induced autophagy through microRNA-30a in mycobacteria infected macrophages.

  2019cites this paper
• Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis

  2018cites this paper
• Mycobacteria and Autophagy: Many Questions and Few Answers.

  2017cites this paper
• Local Pulmonary Host‐Directed Therapies for Tuberculosis via Aerosol Delivery

  2016cites this paper
• Inhaled drug treatment for tuberculosis: Past progress and future prospects.

  2016cites this paper
• Microparticles as novel biomarkers/effectors in severe sepsis

  2015cites this paper
• Extracellular traps and macrophages: new roles for the versatile phagocyte

  2015cites this paper
• Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis

  2015cites this paper
• Optimization of conditions for expression of recombinant interferon-γ in E.coli

  2014cites this paper
• Adenosine Deaminase Acting on RNA-1 (ADAR1) Inhibits HIV-1 Replication in Human Alveolar Macrophages

  2014cites this paper
• THE POTENTIAL ROLE OF VACCINES IN THE MANAGEMENT/ CONTROL OF MDR/ XDR-TB

  2014cites this paper
• Function and Potentials of M. tuberculosis Epitopes

  2014cites this paper
• Host-Directed Therapeutics for Tuberculosis: Can We Harness the Host?

  2013cites this paper
• Wedelolactone, a Naturally Occurring Coumestan, Enhances Interferon-γ Signaling through Inhibiting STAT1 Protein Dephosphorylation*

  2013cites this paper
• IMPACT DE L'INTERFÉRON GAMMA SUR LA PRODUCTION DE LA KÉRATINE 15 DANS LES KÉRATINOCYTES ISOLÉS DE LA PEAU DE PATIENTS ATTEINTS D'ÉPIDERMOLYSE BULLEUSE SIMPLEX

  2013cites this paper
• Bases structurales de la régulation des cytokines par les héparanes sulfates : régulation génique et optimisation d’un inhibiteur de l’interféron-gamma.

  2013cites this paper
• Elevated IP-10 and IL-6 from bronchoalveolar lavage cells are biomarkers of non-cavitary tuberculosis.

  2013cites this paper
• Biological Therapies in Development for COPD

  2012cites this paper
• Estudio del rol de la vía de PD-1 sobre la respuesta inmune de células Nk y de los mecanismos inmunológicos inducidos por las células Th9 frente a la infección por M. tuberculosis

  2012cites this paper
• The effect of combination IFN-alpha-2a with usual antituberculosis chemotherapy in non-responding tuberculosis and diabetes mellitus: a case report and review of the literature

  2012cites this paper
• Adjunct immunotherapies for tuberculosis.

  2012cites this paper
• The Immunopathogenesis of Chronic Obstructive Pulmonary Disease

  2012cites this paper
• In vitro differentiation of human macrophages with enhanced antimycobacterial activity.

  2011cites this paper
• Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

  2011cites this paper
• The flavonoid dioclein reduces the production of pro-inflammatory mediators in vitro by inhibiting PDE4 activity and scavenging reactive oxygen species.

  2010cites this paper
• New drugs and regimens for treatment of TB

  2010cites this paper
• Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis

  2009cites this paper
• Cytokine therapy of tuberculosis at the crossroads

  2009cites this paper
• Impaired activation of Stat1 and c‐Jun as a possible defect in macrophages of patients with active tuberculosis

  2009cites this paper
• Clinical Use of Interferon‐γ

  2009cites this paper
• Inhaled Drug Delivery for Tuberculosis Therapy

  2009cites this paper
• Inhaled therapeutics for prevention and treatment of pneumonia

  2009cites this paper
• Inhaledtherapeuticsfor preventionandtreatmentof pneumonia

  2009cites this paper
• Gene expression profiles of bronchoalveolar cells in pulmonary TB.

  2008cites this paper
• Cytokines as immunomodulators in tuberculosis therapy.

  2008cites this paper
• Therapeutic Effect of Recombinant Adenovirus Encoding Interferon-γ in a Murine Model of Progressive Pulmonary Tuberculosis.

  2008cites this paper
• Therapeutic effect of recombinant adenovirus encoding interferon-gamma in a murine model of progressive pulmonary tuberculosis.

  2008cites this paper
• Subcutaneously administered interferon-gamma for the treatment of multidrug-resistant pulmonary tuberculosis.

  2007cites this paper
• The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.

  2007cites this paper
• IFN-gamma therapy of tuberculosis and related infections.

  2007cites this paper
• Low dose BCG vaccination in mice : immune responses and implications for tuberculosis control

  2007cites this paper
• Interferon: cellular executioner or white knight?

  2007cites this paper
• IFN-γ Therapy of Tuberculosis and Related Infections

  2007influential citation
• Management of multidrug‐resistant tuberculosis: Update 2007

  2007cites this paper
• Mucosal immunotherapy of tuberculosis: is there a value in passive IgA?

  2006cites this paper
• Inhaled cytokines and cytokine antagonists.

  2006cites this paper
• Murine models of susceptibility to tuberculosis.

  2005cites this paper
• Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages.

  2005cites this paper
• Randomized , Double-Blind , Placebo-Controlled , Dose-Escalating Study of Aerosolized Interferon Gamma-1 b in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

  2005influential citation
• Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalating Study of Aerosolized Interferon Gamma‐1b in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

  2005influential citation
• Infectious lung complications in patients with HIV/AIDS

  2005cites this paper
• Mycobacterium tuberculosis-Induced CXCR4 and Chemokine Expression Leads to Preferential X4 HIV-1 Replication in Human Macrophages1

  2004cites this paper
• Functional and genetic assessment of IFN-gamma receptor in patients with clinical tuberculosis.

  2004cites this paper
• Regional Deposition of Aerosolized Interferon-γ in Pulmonary Tuberculosis

  2004cites this paper
• Exogenous Gamma and Alpha/Beta Interferon Rescues Human Macrophages from Cell Death Induced by Bacillus anthracis

  2004cites this paper
• Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis.

  2004cites this paper
• Specific Engagement of TLR4 or TLR3 Does Not Lead to IFN-β-Mediated Innate Signal Amplification and STAT1 Phosphorylation in Resident Murine Alveolar Macrophages1

  2004cites this paper
• Surfactant Protein A Modulates the Inflammatory Response in Macrophages during Tuberculosis

  2004cites this paper
• Macrophages Preferential X 4 HIV-1 Replication in Human and Chemokine Expression Leads to-Induced CXCR 4 Mycobacterium tuberculosis

  2004cites this paper
• Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis.

  2004cites this paper
• Aerosolized Gamma Interferon (IFN-γ) Induces Expression of the Genes Encoding the IFN-γ-Inducible 10-Kilodalton Protein but Not Inducible Nitric Oxide Synthase in the Lung during Tuberculosis

  2004cites this paper
• Preferential X4 HIV-1 Replication in Human and Chemokine Expression Leads to -Induced CXCR4 Mycobacterium tuberculosis

  2004cites this paper
• IL‐10 down‐regulates costimulatory molecules on Mycobacterium tuberculosis‐pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients

  2004cites this paper
• Function and potentials of M. tuberculosis epitopes

  year unknowncites this paper